clinical trials

Lilly’s Cholesterol Pill Shows Early Promise in Phase I Study
BioSpace
Tue, 08/29/23 - 11:15 am
Eli Lilly
muvalaplin
clinical trials
cholesterol
Merck Initiates Phase 3 Clinical Program for Oral PCSK9 Inhibitor Candidate MK-0616
Drugs.com
Mon, 08/28/23 - 08:23 pm
Merck
clinical trials
MK-0616
hypercholesterolemia
Bayer Pushes Ahead With Parkinson’s Cell Therapy on Heels of Positive Phase 1 Data
MedCity News
Mon, 08/28/23 - 08:21 pm
Bayer
cell therapy
Parkinson's Disease
clinical trials
Novartis: Leqvio Provides Low-density Lipoprotein Cholesterol Reduction Beyond 6 Years Of Treatment
RTT News
Mon, 08/28/23 - 12:05 pm
Novartis
Leqvio
LDL cholesterol
clinical trials
Amgen Presents Late-Breaking Phase 2 Olpasiran Data at ESC 2023
BioSpace
Mon, 08/28/23 - 12:02 pm
Amgen
cardiovascular disease
olpasiran
clinical trials
FDA grants clearance to Harbour’s IND for solid tumors therapy trial
Clinical Trials Arena
Mon, 08/28/23 - 11:58 am
Harbour BioMed
clinical trials
HBM9033
solid tumors
Valneva reports data from chikungunya vaccine trial in adolescents
Clinical Trials Arena
Mon, 08/28/23 - 10:44 am
Valneva
clinical trials
VLS1553
chikungunya virus
Merck, Eisai Drop Phase III Keytruda-Lenvima Trial for Head and Neck Cancer
BioSpace
Sun, 08/27/23 - 04:40 pm
Merck
Eisai
Keytruda
Lenvima
clinical trials
head and neck cancer
BridgeBio presents detailed positive results from Phase 3 ATTRibute-CM study of acoramidis for patients with transthyretin amyloid cardiomyopathy (ATTR-CM)
Yahoo/GlobeNewswire
Sun, 08/27/23 - 04:28 pm
Bridge Bio
clinical trials
acoramidis
ATTR
ATTR-CM
On a roll, Novo's star obesity drug Wegovy shows benefits in patients with heart failure
Fierce Pharma
Fri, 08/25/23 - 11:54 am
Novo Nordisk
Wegovy
heart failure
clinical trials
Merck bets big on oral PCSK9 inhibitor, putting 6-year outcome study at heart of phase 3 program
Fierce Biotech
Fri, 08/25/23 - 09:57 am
Merck
PCSK9 inhibitors
clinical trials
cardiovascular disease
cholesterol
MK-0616
Cabometyx study ends early after researchers see 'dramatic' benefits in neuroendocrine tumors, Exelixis says
Fierce Pharma
Thu, 08/24/23 - 08:37 pm
Carbometyx
Exelixis
clinical trials
neuroendocrine tumors
Pfizer steers group B strep vax towards late-stage immunogenicity study over complex efficacy trial
Fierce Biotech
Thu, 08/24/23 - 08:29 pm
Pfizer
vaccines
Group B Strep
clinical trials
Roche’s Divarasib Scores Phase I Win in KRAS-Mutated Solid Tumors
BioSpace
Thu, 08/24/23 - 11:50 am
Roche
Genentech
divarasib
KRAS inhibitors
solid tumors
clinical trials
Lilly’s Retevmo Shows Superior Survival in Phase III Thyroid Cancer Trial
BioSpace
Wed, 08/23/23 - 10:12 am
Eli Lilly
Retevmo
thyroid cancer
medullary thyroid cancer
clinical trials
Exelixis
Capometyx
Sanofi
Caprelsa
Roche posts interim TIGIT overall survival data after 'inadvertent disclosure,' sending stocks up
Fierce Biotech
Wed, 08/23/23 - 10:10 am
Roche
Tigit
clinical trials
lung cancer
non-small cell lung cancer
tiragolumab
Malaria vaccine-drug combo achieves 'dramatic' results
Pharmaphorum
Wed, 08/23/23 - 09:58 am
GSK
Mosquirix
malaria
vaccines
clinical trials
Magenta Medical completes enrolment for world’s smallest heart pump trial
Clinical Trials Arena
Wed, 08/23/23 - 09:56 am
Magenta Medical
devices
Medtech
heart pumps
clinical trials
percutaneous coronary intervention
Pfizer cuts enrollment for Lyme disease trial after CRO debacle
Fierce Biotech
Tue, 08/22/23 - 11:32 pm
Pfizer
vaccines
clinical trials
Lyme disease
Fulcrum's sickle cell disease program is back in business after FDA lifts 6-month hold
Fierce Biotech
Tue, 08/22/23 - 10:01 am
Fulcrum Therapeutics
sickle cell disease
clinical trials
FDX-6058

Pages